Commercialization of
Cord Blood Therapies

Logistics Challenges and Solutions

Umbilical cord blood plays a critical role in treating a wide range of debilitating and life-threatening diseases including leukemia, lymphoma, sickle cell anemia, and many more.

The most promising area of research is how cord blood can be used in regenerative medicine, which can help the body repair, replace, restore or regenerate damaged or diseased cells, tissue and organs.


Our Commercialization of Cord Blood Therapies e-book explains the steps you can take for maintaining the integrity and viability of cord blood and therapies throughout transit:


  • Conduct regular packaging tests
  • Run studies that mirror real life transport scenarios
  • Placement of temperature monitoring devices
  • Utilize technology for timing and communications
     throughout transit
Download our e-book to learn about QuickSTAT's solutions to safely transport cord blood and cord blood-based treatments.


World Cord Blood Day

For the fifth consecutive year, QuickSTAT is World Cord Blood Days official sponsor.


Join us for the free Live Virtual Conference, designed to educate parents and health professionals, on Monday, November 15th, 2021.


Please Complete Form